Opioids are prescription medications or street drugs derived from the opium poppy plant. Opioid use disorder (OUD) is a mental disorder that involves the harmful use of opioids or dependence on them. Symptoms may include a strong desire or difficulty in controlling use, persistent use despite harmful consequences, or physical withdrawal states. Opioid use in …
Heroic Hearts Project, a nonprofit connecting military Veterans struggling with trauma to psychedelic therapy options, and Fireside Project, a nonprofit helping people minimize risks and fulfill the potential of psychedelic experiences, have announced a partnership that will help ensure Veterans processing past psychedelic experiences may receive free, confidential peer support by phone and text message …
Collaboration to Provide Peer-to-Peer Support for Veterans Using Psychedelics Read More »
Lophos Pharmaceuticals Corp. is a Canadian psychedelic research company focused on peyote and its derivatives such as mescaline. Peyote, an endangered plant species with a long history of therapeutic use, has legal status in Canada, but mescaline, a powerful psychedelic molecule derived from the plant, remains a Schedule 3 controlled substance. At their facility, Lophos Pharma …
Psychedelic Research Company Developing Sustainably-Grown Peyote in Canada Read More »
Content warning: Sensitive subject. We all know we’re going to die, but some choose to by suicide. In Canada, about 4000 people die annually by suicide. It causes one-third of deaths in adults ages 45 to 59 years and is the second leading cause of death among youth and young adults aged 15 to 34 …
Psychedelic drugs, like psilocybin, an ingredient found in so-called magic mushrooms, have shown promise in treating a range of addictions and mental health disorders. Yet, there’s something mysterious and almost mystical about their effects, and they are commonly believed to provide unique insights into the nature of consciousness. Now, a new study by Johns Hopkins …
New Study Explores Relationship Between Psychedelics and Consciousness Read More »
The University of Wyoming’s School of Pharmacy and CaaMTech, a Washington state-based company that engineers psychedelic drugs, recently formed a collaboration in which UW researchers will evaluate CaaMTech’s proprietary compounds in addiction models as well as aim to demonstrate their anti-addictive properties. Ana Clara Bobadilla, an assistant professor in the UW School of Pharmacy, will lead …
PSYCH, the premium business-to-business media and content platform for the psychedelic science and healthcare industry, today announced the release of the third issue of its flagship publication, The Psychedelics as Medicine Report. The Psychedelics as Medicine Report is the most comprehensive account of the global psychedelics industry, with unparalleled market intelligence and insights empowering investors, …
PSYCH Publishes Third Edition of The Psychedelics as Medicine Report Read More »
Organization Presents a Memorandum of Regulatory Approval to Health Canada and the Canadian Government A Nanos Research Survey released in August by the Canadian Psychedelic Association (CPA) shows 82 percent of Canadians approve the use of psilocybin-assisted therapy for people suffering from an end-of-life illness and 78 percent would support a government that legalized psilocybin-assisted …
The Project on Psychedelics Law and Regulation Seeks to Advance Evidence-Based Psychedelics Law and Policy The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School has announced a new research initiative, the Project on Psychedelics Law and Regulation (POPLAR). This three-year project will promote safety, innovation, and equity in psychedelics research, commerce, and …
Harvard Law’s Petrie-Flom Center Announces Project on Psychedelics Law and Regulation Read More »
The Faculty of Health Sciences at Queen’s University will create a research collaborative that will serve as an interdisciplinary space for research, innovation and knowledge translation in the field of psychedelics. The launch of the psychedelics research collaborative is enabled by the Dimensions Health Fund in support of the Study of Psychedelics, established by Dimensions Health …
Queen’s University Health Sciences to Launch Psychedelics Research Collaborative Read More »
